His primary areas of investigation include Virology, Immunology, Viral load, Drug resistance and Virus. The study incorporates disciplines such as RNA and Reverse transcriptase in addition to Virology. His Immunology study frequently draws connections to other fields, such as Pharmacotherapy.
His Viral load research includes elements of T cell, Immune system, Peripheral blood mononuclear cell and Human Immunodeficiency Virus DNA. His research integrates issues of Mutation, Acquired immunodeficiency syndrome, Internal medicine and Pharmacology, Drug in his study of Drug resistance. His Lamivudine study combines topics in areas such as Regimen, Efavirenz and Reverse-transcriptase inhibitor.
Huldrych F. Günthard mostly deals with Virology, Immunology, Viral load, Internal medicine and Virus. Huldrych F. Günthard has researched Virology in several fields, including RNA, Antibody and Drug resistance. His study focuses on the intersection of Drug resistance and fields such as Lamivudine with connections in the field of Reverse-transcriptase inhibitor.
His study in Immune system, Viremia, Viral disease, Hepatitis C virus and Antigen is done as part of Immunology. His Viral load research is multidisciplinary, relying on both Drug holiday, Surgery and T cell. His work on Virus is being expanded to include thematically relevant topics such as Peripheral blood mononuclear cell.
His main research concerns Internal medicine, Cohort study, Viral load, Dolutegravir and Men who have sex with men. His work on Confidence interval, Odds ratio, Cohort and Interquartile range is typically connected to Cart as part of general Internal medicine study, connecting several disciplines of science. His Cohort study research is multidisciplinary, incorporating perspectives in Exome sequencing, Population study, Phylogenetic tree, Hazard ratio and Prospective cohort study.
His Viral load research is included under the broader classification of Immunology. His Dolutegravir research also works with subjects such as
Huldrych F. Günthard mainly investigates Internal medicine, Cohort study, Men who have sex with men, Hepatitis C and Incidence. The Internal medicine study combines topics in areas such as Dolutegravir and Abacavir. Huldrych F. Günthard focuses mostly in the field of Cohort study, narrowing it down to topics relating to Prospective cohort study and, in certain cases, Observational study, Unsafe Sex, Viral load and Seroconversion.
The various areas that Huldrych F. Günthard examines in his Medical record study include Odds ratio and Drug resistance. His studies deal with areas such as RNA, Antibody and Virology as well as Odds ratio. His research investigates the connection with Drug resistance and areas like Integrase which intersect with concerns in Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel
Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
JAMA (2008)
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
Joseph K. Wong;Marjan Hezareh;Huldrych F. Günthard;Diane V. Havlir.
Science (1997)
Update of the Drug Resistance Mutations in HIV-1.
Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard.
Topics in HIV medicine : a publication of the International AIDS Society, USA (2008)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai.
Gastroenterology (2010)
2011 update of the drug resistance mutations in HIV-1.
V A Johnson;Calvez;H F Gunthard;R Paredes.
Topics in antiviral medicine (2011)
2017 Update of the Drug Resistance Mutations in HIV-1.
Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2016)
2015 Update of the Drug Resistance Mutations in HIV-1.
Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2015)
2014 Update of the drug resistance mutations in HIV-1.
Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson.
Topics in antiviral medicine (2014)
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel
Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio.
JAMA (2016)
Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel
Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Françoise Brun Vézinet.
Clinical Infectious Diseases (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Universita della Svizzera Italiana
University of Lausanne
University of Zurich
Geneva College
University Hospital of Basel
University of Bern
University of Basel
University of St. Gallen
University of Zurich
École Polytechnique Fédérale de Lausanne
City University of Hong Kong
Palo Alto Research Center
California Institute of Technology
Qualcomm (United Kingdom)
Samsung (South Korea)
University College Dublin
Texas A&M University
Southwest Jiaotong University
Beijing Institute of Technology
Harvard University
University of South Florida
University of Rennes 1
Australian Catholic University
Rutgers, The State University of New Jersey
Goldsmiths University of London
University of Maryland, College Park